Emalex Biosciences (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- March 23, 2021
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Founders
- Jeff Aronin
- Company Description
- Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
- Market
- Central nervous system movement disorders and fluency disorders
- Location
- Chicago, IL, USA
- Coinvestors
- Fidelity Management & Research Company, Paragon Biosciences, Valor Equity Partners